Stockholders Equity | Note 6. Stockholders Equity Fiscal 2016 Stock Transactions During the year ended February 29, 2016, the Company entered into stock purchase agreements and issued 4,927,000 restricted common shares at $0.10 per share, for total cash proceeds of $895,250. The restricted common shares were valued based at the cash sales price of $0.10. Each of these shares included 1 year warrants with an exercise price of $0.15. The fair market value of the warrants issued during the year ended February 29, 2016 was $152,628. The relative fair market value of the shares and warrants to the cash received were $179,906 and $98,594, respectively. On January 1, 2016, 750,000 common shares were issued into escrow at par value of $7,500 in preparation by the Company for an acquisition to occur during Q117. On January 1, 2016, the Company issued 3,312,811 common shares to Robert Monster, CEO, in accordance with his employment agreement dated May 18, 2015. The shares were valued based on the employment agreement date. As 2,597,761 shares were earned due to the one year term of the employment agreement which has not yet completed, the stock based compensation of $779,325 was recorded during the year ended February 29, 2016. The remaining shares which were not yet vested were recorded as a subscription receivable to be recorded in the 2017 fiscal year upon the completion of the employment agreement term. On February 10, 2016, Robert Monster, CEO converted $129,231 of his accrued salary into 1,292,310 common shares and 1 year stock options with an exercise price of $0.15. The shares and warrants were valued on the conversion date in the amounts of $109,846 and $19,385, respectively. As the value of the shares and warrants equaled the conversion amount of accrued salary, no gain or loss was recorded as a result of this transaction. During the year ended February 29, 2016, 41,000 common shares were issued for stock payables from the 2015 fiscal year which amounted to $11,500 which was previously recorded as a stock payable as of February 28, 2015. Fiscal 2015 Stock Transactions During the three months ended February 28, 2015, the Company entered into stock purchase agreements and issued 260,000 restricted common shares at $0.25 per share, for total cash proceeds of $65,000. The restricted common shares were valued based on the cash sales price. The Company also entered into stock purchase agreements at $0.25 per share for total cash proceeds of $9,000 for which the 36,000 restricted common shares were not issued as of February 28, 2015. The $9,000 is included in the stock payable balance of $11,500 as of February 28, 2015. During the three months ended November 30, 2014, the Company entered into stock purchase agreements and issued 268,000 restricted common shares at $0.25 per share, for total cash proceeds of $67,000. The restricted common shares were valued based at the market price on the grant date. On October 22, 2014, the Company issued 106,800 restricted common shares at $0.25 per share to the Companys former contract Chief Financial Officer as settlement for the outstanding balance of his related party accounts payable balance of $26,700 related to past consulting fees. Even though the fair value of the liability was $26,700, and the fair value of the shares granted as of October 9, 2014, the date of the oral agreement, was $16,020 (based on market value of $0.15 per share), the balance of $10,680 was recognized in additional paid-in capital due to the related party status. On August 7, 2014, the Company entered into a stock purchase agreement and issued 60,000 restricted common shares at $0.25 per share, for total cash proceeds of $15,000. The restricted common shares were valued based at the market price on the grant date. On May 6, 2014, the Company entered into a stock purchase agreement and issued 5,000 restricted common shares at $0.50 per share, for total cash proceeds of $2,500. The restricted common shares were valued based at the market price on the grant date. The stockholder purchased 10,000 shares for $5,000 but the transfer agent only issued 5,000 shares (in February 2015). The other $2,500 received on May 6, 2014 is recorded as stock payable as of February 28, 2015 until the remaining shares are issued in the first quarter of fiscal 2016. On April 25, 2014, the Company entered into a stock purchase agreement and issued 10,000 restricted common shares at $0.50 per share, for total cash proceeds of $5,000. The restricted common shares were valued based at the market price on the grant date. Stock Warrants As of February 29, 2016 Stockholders purchasing stock during the fourth quarter of fiscal year 2016 were granted a one year warrant for each share of stock purchased. The $0.15 warrants vested immediately and expire January 1, 2017. On December 4, 2015, one board member was issued 200,000 warrants as compensation to purchase shares of the Company stock at $0.10 per share. The warrants vested immediately and expire December 3, 2025. The total estimated value using the Black-Scholes Model, based on a volatility rate of 125% and a call option value of $0.13 was $25,994. On December 4, 2015, one consultant was issued 200,000 warrants as compensation to purchase shares of the Company stock at $0.10 per share. The warrants vested immediately and expire December 3, 2025. The total estimated value using the Black-Scholes Model, based on a volatility rate of 125% and a call option value of $0.13 was $25,944. On September 10, 2015, one consultant was issued 200,000 warrants as compensation to purchase shares of the Company stock at the closing price as of September 9, 2015 of $0.30 per share. The warrants vested immediately and expire on September 10, 2025. The total estimated value using the Black-Scholes Model, based on a volatility rate of 121% and a call option value of $0.285 was $57,001. On September 10, 2015, one consultant was issued 200,000 warrants as compensation to purchase shares of the Company stock at the price of $0.30 per share. The warrants vested immediately and expire on September 10, 2025. The total estimated value using the Black-Scholes Model, based on a volatility rate of 121% and a call option value of $0.285 was $57,001. On September 10, 2015, one consultant was issued 100,000 warrants as compensation to purchase shares of the Company stock at the price of $0.30 per share. The warrants vested immediately and expire on September 10, 2025. The total estimated value using the Black-Scholes Model, based on a volatility rate of 121% and a call option value of $0.285 was $28,500. On May 5, 2015, Jeffrey Mills, a Director, was issued 200,000 warrants as compensation to purchase shares of the Company stock at the price as of May 4, 2015 of $0.25 per share. The warrants vested immediately and are exercisable until May 5, 2025. The total estimated value using the Black-Scholes Model, based on a volatility rate of 125% and a call option value of $0.24 was $47,817. On May 5, 2015, one consultant was issued 200,000 warrants as compensation to purchase shares of the Company stock at the price of $0.25 per share. The warrants vested immediately and are exercisable until May 5, 2025. The total estimated value using the Black-Scholes Model, based on a volatility rate of 125% and a call option value of $0.24 was $47,817. On May 5, 2015, one consultant was issued 50,000 warrants as compensation to purchase shares of the Company stock at the price of $0.25 per share. The warrants vested immediately and are exercisable until May 5, 2025. The total estimated value using the Black-Scholes Model, based on a volatility rate of 125% and a call option value of $0.24 was $11,954. On May 5, 2015, Darvin Habben, Chairman of the Board, was issued 400,000 warrants as compensation to purchase shares of the Company stock at the price of $0.25 per share. The warrants vested immediately and are exercisable until May 5, 2025. The total estimated value using the Black-Scholes Model, based on a volatility rate of 125% and a call option value of $0.24 was $95,634. On April 3, 2015, one consultant was issued 300,000 warrants as compensation to purchase shares of the Company stock at the price of $0.15 per share. The warrants vested immediately and are exercisable until April 3, 2025. The total estimated value using the Black-Scholes Model, based on a volatility rate of 122% and a call option value of $0.14 was $42,808. On April 21, 2014, the Company canceled 300,000 stock purchase warrants issued to four consultants on January 10, 2014. The Company utilized the following key assumptions in computing the fair value of the warrants using the Black-Scholes pricing model: April 3, May 5, September 10, 2015 2015 2015 Weighted-average volatility 122% 125% 121% Expected dividends None None None Expected term (in years) 10.00 10.00 10.00 Weighted-average risk-free interest rate 1.92% 2.19% 2.23% Weighted-average fair value of warrants granted $0.14 $0.21 $0.29 December 4, January 1, 2015 2016 Weighted-average volatility 122% 126% Expected dividends None None Expected term (in years) 10.00 1.00 Weighted-average risk-free interest rate 1.92% 0.66% Weighted-average fair value of warrants granted $0.14 $0.15 The following table summarizes information about the Companys stock warrant changes during the years ended February 29, 2016 and February 28, 2015: Number of Warrants Outstanding - February 28, 2014 495,000 Granted 700,000 Canceled or expired (495,000) Outstanding - February 28, 2015 700,000 Granted 4,510,000 Canceled or expired (700,000) Outstanding - February 28, 2016 4,510,000 Exercisable at February 28, 2016 4,510,000 The following table summarizes information about stock warrants outstanding as of February 29, 2016: Exercise Price Number Outstanding Weighted Average Remaining Life (years) Weighted Average Exercise Price Number Exercisable Weighted Average Exercisable Price $0.25 300,000 9.08 $0.24 300,000 $0.24 $0.25 850,000 9.17 $0.24 850,000 $0.24 $0.30 500,000 9.50 $0.28 500,000 $0.28 $0.10 400,000 9.75 $0.13 400,000 $0.13 $0.15 2,460,000 0.83 $0.07 2,460,000 $0.07 $0.15 - $0.30 4,510,000 4.70 $0.14 4,510,000 $0.14 The Company recorded stock-based compensation expense of $388,532 and $62,494 for all outstanding stock warrants for the years ended February 29, 2016 and February 28, 2015, respectively. This expense is included in selling, general and administrative expense. |